Osteoarthritis, also known as degenerative joint disease, is the most common joint pathology. As a degenerative disease, osteoarthritis can develop in any joint. Broad classification of osteoarthritis includes two main types such as primary and secondary osteoarthritis. Primary osteoarthritis is of idiopathic origin, i.e. its cause is unknown and is usually characterized by multiple joint damages. Secondary osteoarthritis, usually develops in one joint. Currently, there is no uniform clinical management of these injuries. In addition, it is known that the mentioned lesions are progressive in nature and relapse is possible after treatment. The histopathological and molecular characteristics of the progression of osteoarthritis are of great importance because the prognosis of these lesions cannot be determined only by clinical studies. Currently, available literature data on histopathological characteristics and molecular markers of osteoarthritis are very scarce. There is almost no literature on risk factors for osteoarthritis progression and relapse.
E. R. Vina and C. K. Kwoh, “Epidemiology of osteoarthritis: literature update.,” Curr. Opin. Rheumatol., vol. 30, pp. 160–167, 2018.
M. Cucchiarini, “Basic science of osteoarthritis.,” J. Exp. Orthop., vol. 3, Sep. 2016.
M. J. Lespasio, “Hip Osteoarthritis: A Primer.,” Perm. J., vol. 22, 2018.
K. M. Lee, “Risk factors for osteoarthritis and contributing factors to current arthritic pain in South Korean older adults.,” Yonsei Med. J., vol. 56, pp. 124–131, 2015.
B. Yucesoy, L. E. Charles, B. Baker, and C. M. Burchfiel, “Occupational and genetic risk factors for osteoarthritis: A review,” Work, vol. 50, no. 2. IOS Press, pp. 261–273, 2015. doi: 10.3233/WOR-131739.
Murphy NJ, Eyles JP, and Hunter DJ, “Hip osteoarthritis: Etiopathogenesis and implications for management. ,” Adv Ther , vol. 33, Nov. 2016.
v. M. old M and Munjal A, “Anatomy, Bony Pelvis and Lower Limb, Hip Joint.,” Treasure Island (FL): StatPearls Publishing, 2020.
B. M. Saltzman and J. C. Riboh, “Subchondral Bone and the Osteochondral Unit: Basic Science and Clinical Implications in Sports Medicine.,” Sports Health, vol. 10, p. 412418, 201AD.
S. R. Goldring and M. B. Goldring, “Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk.,” Nat. Rev. Rheumatol., vol. 12, pp. 632–644, Nov. 2016.
B. Xia, di Chen, J. Zhang, S. Hu, H. Jin, and P. Tong, “Osteoarthritis Pathogenesis: A Review of Molecular Mechanisms,” Calcified Tissue International, vol. 95, no. 6. Springer Science and Business Media, LLC, pp. 495–505, Nov. 21, 2014. doi: 10.1007/s00223-014-9917-9.
F. Berenbaum, “Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!),” Osteoarthritis and Cartilage, vol. 21, no. 1. pp. 16–21, Jan. 2013. doi: 10.1016/j.joca.2012.11.012.
A. Mobasheri, S. Saarakkala, M. Finnilä, M. A. Karsdal, A. C. Bay-Jensen, and W. E. van Spil, “Recent advances in understanding the phenotypes of osteoarthritis,” F1000Research, vol. 8. F1000 Research Ltd, 2019. doi: 10.12688/f1000research.20575.1.
L. M. Mullen, G. Chamberlain, and S. Sacre, “Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease.,” pp. 1–10, 2015.
G. Barreto, M. Manninen, and K. K Eklund, “Osteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte Apoptosis.,” Biology (Basel)., vol. 9, Mar. 2020.
Liu Z et al., “Notch signaling in postnatal joint chondrocytes, but not subchondral osteoblasts, is required for articular cartilage and joint maintenance. Osteoarthritis Cartilage.,” vol. 24, 2016.
Taku Saito and Sakae Tanaka, “Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB,” May 2017.
M. Nagao, “Vascular Endothelial Growth Factor in Cartilage Development and Osteoarthritis.,” Sci. Rep., vol. 7, Oct. 2017.
T. Schmidt, “General synovitis score and immunologic synovitis score reflect clinical disease activity in patients with advanced stage rheumatoid arthritis.,” no, pp. 1–9, Apr. 2019.
Bierma-Zeinstra SM and van Middelkoop M, “Osteoarthritis: In search of phenotypes.,” Nat Rev Rheumatol. , 2017.
R. D. Bay-Jensen AC and Kjelgaard-Petersen CF, “Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria.,” Osteoarthritis Cartilage., vol. 24, 2016.
A. Munjal, S. Bapat, D. Hubbard, M. Hunter, R. Kolhe, and S. Fulzele, “Advances in Molecular biomarker for early diagnosis of Osteoarthritis,” Biomol Concepts, vol. 10, no. 1, pp. 111–119, 2019, doi: 10.1515/bmc-2019-0014.
Runhaar J, Sanchez C, Taralla S, Henrotin Y, and Bierma-Zeinstra SM, “Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women. Osteoarthritis and Cartilage.,” Osteoarthritis Cartilage, vol. 24, 2016.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.